<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aiming to detect the most sensitive markers of increased risk of ischemic cerebrovascular diseases <z:chebi fb="17" ids="39025">HDL</z:chebi>, HDL2 and HDL3 cholesterol levels were examined using the ultracentrifugation method in 36 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and 34 healthy subjects of the control group </plain></SENT>
<SENT sid="1" pm="."><plain>The results of the study have shown significant reduction of the total <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> levels in both subfractions, and especially of HDL3 in patients with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This finding was discussed in the light of recent studies of <z:chebi fb="23" ids="18059">lipid</z:chebi> disorders in patients with ischemic cerebrovascular diseases </plain></SENT>
<SENT sid="3" pm="."><plain>It has been concluded that further studies of these diseases should be directed toward <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> </plain></SENT>
</text></document>